PHS
BHVN icon

Pekin Hardy Strauss’s Biohaven BHVN Stock Holding History

Pekin Hardy Strauss’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-12,275
Closed -$458K – 365
2024
Q4 		$458K Sell
12,275
-4,700
-28% -$219K 0.06% 257
2024
Q3 		$848K Buy
16,975
+3,675
+28% +$143K 0.11% 169
2024
Q2 		$462K Buy
+13,300
New +$526K 0.06% 229

Other funds holding BHVN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Pekin Hardy Strauss's BHVN Position: Q1 2025 in Review

Pekin Hardy Strauss sold out of Biohaven (BHVN) in Q1 2025, closing a stake of 12,275 shares — an estimated $458K sold.

Pekin Hardy Strauss first reported a position in BHVN in Q2 2024 and held it in 3 quarters. The position peaked at $848K in Q3 2024. 266 funds tracked by Wall St. Rank hold BHVN as of Q1 2025.

  • Pekin Hardy Strauss reported no remaining Biohaven position as of Q1 2025 after selling out during the quarter.
  • Pekin Hardy Strauss sold 12,275 Biohaven shares in Q1 2025, an estimated $458K.
  • Pekin Hardy Strauss first reported a position in Biohaven in Q2 2024 and held it in 3 quarters.
  • Pekin Hardy Strauss's Biohaven position peaked at $848K in Q3 2024.
  • 266 funds tracked by Wall St. Rank held Biohaven as of Q1 2025.

Based on Pekin Hardy Strauss's 13F filing for Q1 2025, filed 30 Apr 2025.